Search for "TV show character's mother described born with CNS stimulant antagonist less than 10 receptors" returned 56 results.

https://documentation.cochrane.org/wwirpt/revman-roadmap/priorities-2022

be scoping the solution and that the development work could be included some time in 2022. Show which versions … we don't need to schedule this on the roadmap Retire Archie has a lower priority than retiring RM5 and moving

https://documentation.cochrane.org/wwirpt/revman-roadmap/previous-quarters/q3q4-2024/update-statistical-methods-for-pairwise-meta-analysis

Communication, KB updates and training dependencies for launch Test data and calculations described before development starts What are the risks related to this roadmap item? Introducing more complexity than necessary

https://documentation.cochrane.org/wwirpt/revman-roadmap/previous-quarters/2020q2-progress-of-revman-web-development/compare-versions

place. Respond to edits made by someone else than me. Identify a problem free version if there are issue … describing how to compare versions (linking to Archie help) implies it is important functionality. The view required

https://documentation.cochrane.org/wwirpt/revman-roadmap/previous-quarters/2021q2-revman-web-development-progress

to a sustainable text editor https://jira.cochrane.org/browse/RMW-1066 (focus: Track changes) 10/05/2021 … started Completed and demoed: Story Roadmap item Released Show more content in tables when generating a pdf

https://documentation.cochrane.org/wwirpt/revman-roadmap/previous-quarters/q42023/migrate-revman-web-to-a-supported-development-platform

having existed for about 10 years. It is not going to disappear from one day to another, and RevMan Web will still … than Angular? At this point, no. Which automated tests can we transfer from AngularJS to Angular? Units tests

https://documentation.cochrane.org/wwirpt/revman-roadmap/previous-quarters/2020q4-revman-web-development/increase-reliability-of-rmw

in the software can be achieved by implementing several improvements in a short period of time than separately over a longer

https://documentation.cochrane.org/wwirpt/scrum-process/story-refinement-checklist

story (if bigger than 13 points)? After refinement (see Definition of Ready and Done):

https://documentation.cochrane.org/wwirpt/revman-roadmap/previous-quarters/q32023

-centric data; Angular upgrade 25/09/2023 06/10/2023 Angular upgrade 09/10/2023 20/10/2023 Angular upgrade 23/10/2023 03/11/2023 Angular upgrade 06/11/2023 17/11/2023 Angular upgrade Recordings folder

https://documentation.cochrane.org/wwirpt/revman-roadmap/previous-quarters/2019q2-progress-of-revman-web-development

of the Minimum Viable Product (MVP) - 100% of story points completed. Baseline: 55/122. - rhall 10 reviews have had at least 50% of their analyses migrated to study-centric data to the author's satisfaction - trial data. Baseline: 0/10

https://documentation.cochrane.org/wwirpt/revman-roadmap/previous-quarters/2020q2-progress-of-revman-web-development/remove-synchronization-process

the value delivered be measured? Adoption of RevMan Web increases Support team spends less time on synchronizing

https://documentation.cochrane.org/wwirpt/revman-roadmap/previous-quarters/2021q3-revman-web-development-progress

11/10/2021 Ingest (previous guesstimate 1 sprint, more info from Aries in July) 25 Oct 25/10/2021 … automated testing 11 Oct 11/10/2021 Ingest (previous guesstimate 1 sprint, more info from Aries in July

https://documentation.cochrane.org/wwirpt/revman-roadmap/previous-quarters/2024q1

&referrerScenario=AddressBarCopied%2Eview&ga=1 Sprint Goal 🎯 We can show PPM pilot groups that we have actioned some

https://documentation.cochrane.org/wwirpt/revman-roadmap/previous-quarters/2021q2-revman-web-development-progress/progress-on-priorities-q2-2021/update-to-a-sustainable-text-editor

collaborative features in a shorter time frame than if implemented with CKEditor 4. Experiment to get proof of concept … (Full-text view) Table editing is more rudimentary than CKEditor 4, so customization is require Opportunity cost

https://documentation.cochrane.org/wwirpt/revman-roadmap/previous-quarters/2022q1-revman-web-development-progress/progress-on-quarterly-objectives

It is a long-term objective is to retire RevMan 5. The work described below is aimed at contributing to this in Q1: Find and replace Non-Cochrane reviews Improve how data gets in to RevMan Web It is a long-term

https://documentation.cochrane.org/wwirpt/revman-roadmap/previous-quarters/2020q1-progress-of-revman-web-development/sensitivity-analysis

checking reviews, but many are checking robustness of analyses as described below (under ‘Authors and editors should

https://documentation.cochrane.org/wwirpt/revman-roadmap/previous-quarters/2020q3-progress-of-revman-web-development/performance-optimization

just too long (independent of browser and connection)" "Sometimes, it takes time and shows unknown error

https://documentation.cochrane.org/wwirpt/revman-roadmap/on-hold-not-yet-on-the-roadmap/standardized-workflow-for-study-references

be checked out to RevMan 5 Study references can't be added, removed, modified, or attached to studies other than via the CRS Studies can't be added or removed other than via the CRS (TBC: editing of "General" study information

https://documentation.cochrane.org/wwirpt/revman-roadmap/previous-quarters/2021q2-revman-web-development-progress/progress-on-priorities-q2-2021

Now 26/04/2021 Update to a sustainable text editor https://jira.cochrane.org/browse/RMW-1066 Now 10 … /2021 Update to a sustainable text editor https://jira.cochrane.org/browse/RMW-1066 Now 10/05/2021

https://documentation.cochrane.org/wwirpt/revman-roadmap/previous-quarters/2020q2-progress-of-revman-web-development

: Show yellow markings and track changes in the view Compare figures Ask support to Revert to a review version

https://documentation.cochrane.org/wwirpt/revman-roadmap/previous-quarters/q42023

scores increase by 10% Objective: Improve data interoperability with other tools in the review production ecosystem

https://documentation.cochrane.org/wwirpt/revman-roadmap/previous-quarters/2023q2/improve-how-data-gets-into-revman-web-part-iii/improve-study-data-import

systems and processes Future of review production project: Retire RevMan 5 (promoting RevMan Web as better than

https://documentation.cochrane.org/wwirpt/revman-roadmap/previous-quarters/2022q3-revman-web-development-progress/support-all-review-types-dta-reviews-part-ii

= More than 6 weeks.

https://documentation.cochrane.org/wwirpt/revman-roadmap/archived-roadmap-items/archived-screening-integration-with-covidence

than 6 weeks. High risk of increasing in scope as we learn more and due to dependency on another team.

https://documentation.cochrane.org/wwirpt/revman-roadmap/previous-quarters/2020q2-progress-of-revman-web-development/revert-to-previous-version

of the review is in a better state than the draft version. Revert can also be used to re-publish protocols where

https://documentation.cochrane.org/wwirpt/revman-roadmap/previous-quarters/2022q2-revman-web-development-progress/support-all-review-types-dta-reviews-part-i

and the capacity of the team at the time of estimation (June 2020). Large: 3 or more sprints = More than 6 weeks.